Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9855320rdf:typepubmed:Citationlld:pubmed
pubmed-article:9855320lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:9855320lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:9855320lifeskim:mentionsumls-concept:C0851347lld:lifeskim
pubmed-article:9855320lifeskim:mentionsumls-concept:C0059985lld:lifeskim
pubmed-article:9855320pubmed:issue6lld:pubmed
pubmed-article:9855320pubmed:dateCreated1999-2-10lld:pubmed
pubmed-article:9855320pubmed:abstractTextTo describe the pharmacokinetics and pharmacodynamics of fludarabine in patients with rheumatoid arthritis (RA).lld:pubmed
pubmed-article:9855320pubmed:languageenglld:pubmed
pubmed-article:9855320pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855320pubmed:citationSubsetIMlld:pubmed
pubmed-article:9855320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855320pubmed:statusMEDLINElld:pubmed
pubmed-article:9855320pubmed:issn0277-0008lld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:BoumpasD TDTlld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:FesslerBBlld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:PucinoFFlld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:DavisJ CJCJrlld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:KnebelWWlld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:YarboroCClld:pubmed
pubmed-article:9855320pubmed:authorpubmed-author:SandersW DWDlld:pubmed
pubmed-article:9855320pubmed:issnTypePrintlld:pubmed
pubmed-article:9855320pubmed:volume18lld:pubmed
pubmed-article:9855320pubmed:ownerNLMlld:pubmed
pubmed-article:9855320pubmed:authorsCompleteYlld:pubmed
pubmed-article:9855320pubmed:pagination1224-9lld:pubmed
pubmed-article:9855320pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:meshHeadingpubmed-meshheading:9855320-...lld:pubmed
pubmed-article:9855320pubmed:articleTitleThe pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid arthritis.lld:pubmed
pubmed-article:9855320pubmed:affiliationClinical Pharmacokinetics Research Laboratory and Clinical Section, Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland 20892-1196, USA.lld:pubmed
pubmed-article:9855320pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9855320pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9855320pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:9855320pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9855320lld:pubmed